1 recruiting. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow Next-generation Sequencing: new trials by email Literature Review of Next-generation Sequencing trials Research Report on Next-generation Sequencing
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Pazopanib Combined With Palbociclib for Refractory Solid Tumors With Co-amplified in the 11q13(FGF3/4/19/CCND1) Pazopanib Oral Tablet, Palbociclib - Solid Tumor, Adult, Next-generation Sequencing | Phase 1 / Phase 2 | Recruiting | Tianjin Medical University Second Hospital | 65 | 2024-11-27 | 2025-03-26 |
palbociclib (1) · pazopanib (1)
Tianjin Medical University Second Hospital (1)
China (1)